Skip to main content
Clinical Trials/JPRN-UMIN000027775
JPRN-UMIN000027775
Completed
Phase 2

Prospective multicenter study regarding the efficacy of Gemcitabine (gemzar) plus nab-Paclitaxel (Abraxane) regimen for locally advanced pancreatic cancer - GEAR study

Kyushu-Yamaguchi study group of therapy for pancreatobiliary cancer0 sites37 target enrollmentJuly 1, 2017

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
pancreatic cancer
Sponsor
Kyushu-Yamaguchi study group of therapy for pancreatobiliary cancer
Enrollment
37
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2017
End Date
December 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kyushu-Yamaguchi study group of therapy for pancreatobiliary cancer

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Present or previous (within 5 years) double cancer except for carcinoma in situ 2\) Pregnant females, possibly pregnant females, females feeding babies and males wishing partners' pregnancy 3\) Active infection 4\) Severe mental disorder 5\) Interstitial pneumonia or pulmonary fibrosis 6\) Severe heart disease, liver disease and uncontrolled diabetes 7\) Patients positive for HBs antigen 8\) Patients inadequate for enhanced CT scan 9\) Severe allergy for drugs 10\) Patients with inadequate condition

Outcomes

Primary Outcomes

Not specified

Similar Trials